Healthcare provider profile · identity verified

Michael Anthony Zane, D.O.

Internal Medicine · SEFFNER, FL · NPI 1043206816

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	570	174
Amlodipine Besylate	Amlodipine Besylate	495	150
Levothyroxine Sodium	Levothyroxine Sodium	393	111
Losartan Potassium	Losartan Potassium	337	99
Rosuvastatin Calcium	Rosuvastatin Calcium	290	84
Lisinopril	Lisinopril	276	81
Albuterol Sulfate Hfa	Albuterol Sulfate	270	80
Furosemide	Furosemide	252	95
Omeprazole	Omeprazole	246	82
Simvastatin	Simvastatin	235	66
Gabapentin	Gabapentin	234	75
Fluticasone Propionate	Fluticasone Propionate	232	95
Metformin Hcl	Metformin Hcl	228	75
Pantoprazole Sodium	Pantoprazole Sodium	225	69
Metoprolol Tartrate	Metoprolol Tartrate	218	67
Sertraline Hcl	Sertraline Hcl	190	59
Eliquis	Apixaban	187	39
Tamsulosin Hcl	Tamsulosin Hcl	179	58
Alprazolam	Alprazolam	170	39
Metoprolol Succinate	Metoprolol Succinate	166	52
Carvedilol	Carvedilol	158	51
Prednisone	Prednisone	145	110
Potassium Chloride	Potassium Chloride	144	45
Alendronate Sodium	Alendronate Sodium	139	43
Tramadol Hcl	Tramadol Hcl	139	39
Hydrochlorothiazide	Hydrochlorothiazide	131	47
Buspirone Hcl	Buspirone Hcl	125	43
Finasteride	Finasteride	122	39
Baclofen	Baclofen	118	48
Glipizide	Glipizide	116	34
Clopidogrel	Clopidogrel Bisulfate	114	30
Trazodone Hcl	Trazodone Hcl	112	36
Pravastatin Sodium	Pravastatin Sodium	106	31
Famotidine	Famotidine	105	36
Meloxicam	Meloxicam	97	32
Allopurinol	Allopurinol	86	25
Warfarin Sodium	Warfarin Sodium	79	16
Doxycycline Hyclate	Doxycycline Hyclate	78	72
Montelukast Sodium	Montelukast Sodium	74	23
Ibuprofen	Ibuprofen	69	25
Azithromycin	Azithromycin	67	59
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	66	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	64	17
Celecoxib	Celecoxib	63	29
Hydralazine Hcl	Hydralazine Hcl	62	20
Tizanidine Hcl	Tizanidine Hcl	62	19
Atenolol	Atenolol	59	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	59	42
Oxybutynin Chloride	Oxybutynin Chloride	59	18
Methylprednisolone	Methylprednisolone	56	51
Novolin N	Insulin Nph Human Isophane	56	11
Duloxetine Hcl	Duloxetine Hcl	52	23
Glimepiride	Glimepiride	50	14
Temazepam	Temazepam	50	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	48	17
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	48	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	47	suppressed
Lorazepam	Lorazepam	46	suppressed
Sildenafil Citrate	Sildenafil Citrate	44	14
Triamcinolone Acetonide	Triamcinolone Acetonide	44	28
Amoxicillin	Amoxicillin	43	38
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	13
Escitalopram Oxalate	Escitalopram Oxalate	42	14
Ezetimibe	Ezetimibe	42	16
Ketoconazole	Ketoconazole	42	12
Memantine Hcl	Memantine Hcl	41	12
Mirtazapine	Mirtazapine	40	13
Ozempic	Semaglutide	40	suppressed
Meclizine Hcl	Meclizine Hcl	39	19
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	39	suppressed
Donepezil Hcl	Donepezil Hcl	38	15
Lantus	Insulin Glargine,hum.Rec.Anlog	38	11
Mupirocin	Mupirocin	38	30
Glipizide Er	Glipizide	37	11
Nitroglycerin	Nitroglycerin	37	20
Clonidine Hcl	Clonidine Hcl	36	14
Ondansetron Hcl	Ondansetron Hcl	35	16
Nystatin	Nystatin	33	13
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Jardiance	Empagliflozin	31	11
Nifedipine Er	Nifedipine	31	suppressed
Xarelto	Rivaroxaban	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	11
Oxycodone Hcl	Oxycodone Hcl	29	suppressed
Valsartan	Valsartan	29	suppressed
Clonazepam	Clonazepam	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	11
Hydroxyzine Hcl	Hydroxyzine Hcl	28	13
Spironolactone	Spironolactone	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Myrbetriq	Mirabegron	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	25	13
Pregabalin	Pregabalin	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	23
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	24	11
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Digoxin	Digoxin	23	suppressed
Methotrexate	Methotrexate Sodium	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Ciclopirox	Ciclopirox	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Spiriva Respimat	Tiotropium Bromide	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	19
Gemfibrozil	Gemfibrozil	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Bumetanide	Bumetanide	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Testosterone Cypionate	Testosterone Cypionate	20	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	11
Doxycycline Monohydrate	Doxycycline Monohydrate	18	17
Lovastatin	Lovastatin	18	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	18	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Fluconazole	Fluconazole	17	14
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Methimazole	Methimazole	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Metolazone	Metolazone	16	11
Mounjaro	Tirzepatide	16	suppressed
Sulindac	Sulindac	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Roflumilast	Roflumilast	15	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Risperidone	Risperidone	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Topiramate	Topiramate	14	suppressed
Estradiol	Estradiol	13	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Levofloxacin	Levofloxacin	13	13
Metformin Hcl Er	Metformin Hcl	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Naproxen	Naproxen	12	suppressed
Latanoprost	Latanoprost	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error